Abstract
Aim
The study aims to observe the response to treatment with ORS only or ORS + gelatin tannate in two cohorts of pediatric patients with acute diarrhea, with the primary efficacy endpoint being the number of stools at 12 hours from baseline.Methods
Children aged 3 months to 12 years were included in the study. Only children with acute diarrhea, more than 3 liquid stools, and duration inferior to 72 h were included. Number of stools was recorded as absolute number, categorized asResults
Baseline characteristics for the two populations included a mean age of 2.3 years in the ORS group and 2.6 years in the ORS + gelatin tannate group. Children younger than 2 years represented 59.8 and 54.3% in the ORS and ORS + gelatin tannate groups, respectively. Clinical variables such as vomiting, dehydration, weight, and stool decrease index were used to compare the two groups. We found a statistical significant difference between the two groups (p < 0.0001) -- SDI for the ORS group was -0.1894; for the ORS + gelatin tannate group was -0.6023.Conclusions
We observed a significant decrease in the number of stools and an improvement in the consistency of stools in the ORS + gelatin tannate group. Other clinical variables such as vomiting, dehydration, weight, bloody stools, and peritonitis/sepsis signs showed no statistical differences between the two groups, but did show a general trend toward improvement. The Stool Decrease Index (SDI) showed a 18% decrease in the number of stools for the ORS group and 60% for the ORS + gelatin tannate group. The use of ORS + gelatin tannate was associated with a greater decrease in SDI. Gelatin tannate decreased the number of stools at twelve hours in children.Full text links
Read article at publisher's site: https://doi.org/10.4321/s1130-01082009000100005
Read article for free, from open access legal sources, via Unpaywall: https://scielo.isciii.es/pdf/diges/v101n1/original4.pdf
Citations & impact
Impact metrics
Citations of article over time
Article citations
Antimicrobial Activity of Tannic Acid In Vitro and Its Protective Effect on Mice against Clostridioides difficile.
Microbiol Spectr, 11(1):e0261822, 20 Dec 2022
Cited by: 2 articles | PMID: 36537806 | PMCID: PMC9927261
Present and Future Therapeutic Approaches to Barrier Dysfunction.
Front Nutr, 8:718093, 28 Oct 2021
Cited by: 15 articles | PMID: 34778332 | PMCID: PMC8582318
Review Free full text in Europe PMC
Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome.
Therap Adv Gastroenterol, 14:17562848211020570, 30 May 2021
Cited by: 6 articles | PMID: 34104216 | PMCID: PMC8170336
The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults.
Adv Ther, 38(5):2054-2076, 18 Mar 2021
Cited by: 4 articles | PMID: 33738725 | PMCID: PMC7971407
Review Free full text in Europe PMC
Evaluation of a polyherbal formulation for the management of wet litter in broiler chickens: Implications on performance parameters, cecal moisture level, and footpad lesions.
J Adv Vet Anim Res, 6(4):536-543, 30 Oct 2019
Cited by: 0 articles | PMID: 31819883 | PMCID: PMC6882714
Go to all (19) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Evaluation of Gelatin Tannate Against Symptoms of Acute Diarrhea in Pediatric Patients.
Med Sci Monit, 23:2029-2034, 27 Apr 2017
Cited by: 4 articles | PMID: 28448477 | PMCID: PMC5417589
Gelatin Tannate for Acute Childhood Gastroenteritis: A Randomized, Single-Blind Controlled Trial.
Paediatr Drugs, 19(2):131-137, 01 Apr 2017
Cited by: 4 articles | PMID: 28000174
Gelatin tannate versus other antidiarrheal medication in children with acute gastroenteritis: a retrospective, observational study.
J Comp Eff Res, 8(3):187-194, 15 Jan 2019
Cited by: 1 article | PMID: 30644329
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea.
Eur Rev Med Pharmacol Sci, 21(4):873-883, 01 Feb 2017
Cited by: 13 articles | PMID: 28272692
Review